Condition: Post-COVID-19 Syndrome · Fatigue · Sponsor: Medical University of Vienna
The objective of the present study is to demonstrate treatment efficacy of transcranial pulse stimulation for patients with Post-COVID-19 related neurological symptoms (fatigue, cognitive deficits, mood deterioration). Fatigue, as measured by the Fatigue Impact Scale (FIS), will represent the primary outcome variable. The verum treatment will be compared to a sham (placebo) condition.
This description comes directly from the study's public registry record.
Roland Beisteiner, Prof. · +43/(0)1 40400-34080 · roland.beisteiner@meduniwien.ac.at
Michael Mitterwallner, Dr. · +43 650 9626003 · michael.mitterwallner@meduniwien.ac.at
Always discuss trial participation with your own doctor first.
| Medical University of Vienna | Vienna, State of Vienna, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06178952